NASDAQ, TRIB - Trinity Bio ADR
Trinity Biotech (?the ?Group?) develops, acquires, manufactures and markets
medical diagnostic products for the clinical laboratory and point-of-care
(?POC?) segments of the diagnostic market. These products are used to detect
autoimmune, infectious and sexually transmitted diseases, diabetes and disorders
of the blood, liver and intestine. The Group is also a significant provider of
raw materials to the life sciences industry. The Group sells worldwide in over
80 countries through its own sales force and a network of international
distributors and strategic partners.
Trinity Biotech was incorporated as a public limited company (?plc?) registered
in Ireland in 1992. The Company commenced operations in 1992 and, in
October 1992, completed an initial public offering of its securities in the US.
The principal officers of the Group are located at IDA Business Park, Bray, Co
Wicklow, Ireland. The Group has expanded its product base through internal
development and acquisitions. ...
Read SEC Filing on NASDAQ.com »